Gemcitabine: all 1,575 studies that test it

Page 5 of 16. Open to participants first (193), then studies with results posted, then the rest; newest registration first within each.

• Gemcitabine, Oxaliplatin, Tarceva &/or Cisplatin in HCC & Biliary Tree CancersTerminatedNCT00832637Phase 2Results posted
• Phase 2b Study of Cetuximab With Platinum-Based Chemo as First Line Treatment of Recurrent or Advanced NSCLCCompletedNCT00828841Phase 2Results posted
• Gemzar, Cisp, Sunitinib Urothelial CaCompletedNCT00821327Phase 2Results posted
• Gemcitabine in Treating Patients With Recurrent or Persistent Endometrial CancerCompletedNCT00820898Phase 2Results posted
• Gemcitabine and Erlotinib in Treating Patients With Metastatic or Recurrent Pancreatic CancerCompletedNCT00810719Phase 2Results posted
• S0720: Adjuvant Therapy Based on Gene Expression in Stage IA and IB Non-Small Cell Lung CancerCompletedNCT00792701Phase 2Results posted
• S0809: Capecitabine, Gemcitabine, and RT in Patients w/Cholangiocarcinoma of the Gallbladder or Bile DuctCompletedNCT00789958Phase 2Results posted
• A Dose-escalation Study of MK-8776 (SCH 900776) With and Without Gemcitabine in Participants With Solid Tumors or Lymphoma (MK-8776-002/P05248)CompletedNCT00779584Phase 1Results posted
• Chemotherapy and Radiation Therapy in Treating Patients With Stage II or Stage III Bladder Cancer That Was Removed by SurgeryCompletedNCT00777491Phase 2Results posted
• Study of Low-Dose Fractionated Radiotherapy in Patients With Locally Advanced Metastatic Pancreatic CancerCompletedNCT00761345Phase 1Results posted
• Vandetanib Gemcitabine Or Placebo Plus Gemcitabine Or Vandetanib Monotherapy In Advanced Biliary Tract CancerCompletedNCT00753675Phase 2Results posted
• Trial Of AG-013736, Cisplatin, And Gemcitabine For Patients With Squamous Non-Small Cell Lung CancerCompletedNCT00735904Phase 2Results posted
• Gemcitabine and Erlotinib Before and After Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by SurgeryCompletedNCT00733746Phase 2Results posted
• Gemcitabine and Split-dose Cisplatin (GC) Plus Sorafenib in Chemotherapy-naïve Patients With Locally Advanced or Metastatic Urothelial CarcinomaTerminatedNCT00714948Phase 2Results posted
• Study of CGC-11047 When Used in Individual Combinations With 1) Gemcitabine or 2) Docetaxel or 3) Bevacizumab or 4) Erlotinib or 5) Cisplatin or 6) 5-Flurouracil or 7) Sunitinib in Patients With Advanced Solid Tumors or LymphomaCompletedNCT00705874Phase 1Results posted
• A Study of First Line Treatment With Tarceva (Erlotinib) in Combination With Gemcitabine in Patients With Unresectable Advanced and/or Metastatic Non-Small Cell Lung CancerCompletedNCT00701558Phase 2Results posted
• Study of Gemcitabine and Erlotinib Plus Sorafenib (GES) in Metastatic Pancreatic CancerCompletedNCT00696696Phase 2Results posted
• Chemotherapy & Bevacizumab for Human Epidermal Growth Factor Receptor 2 (HER2)/Neu-Negative Stage II/III Breast CancerTerminatedNCT00679029Phase 2Results posted
• A Phase II Trial of Gemcitabine and Oxaliplatin for Triple Negative Metastatic Breast CancerTerminatedNCT00674206Phase 2Results posted
• Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast CancerCompletedNCT00662129Phase 2Results posted
• A Feasibility Phase II Study in the Treatment of Resected Cholangiocarcinoma, Gallbladder, Pancreatic and Ampullary CancersCompletedNCT00660699Phase 2Results posted
• Ph2 Gem/Nov/Rituxan Rel/Ref MantleCellCompletedNCT00656084Phase 2Results posted
• A Dose Escalation Study of Adavosertib (MK-1775) in Combination With Either Gemcitabine, Cisplatin, or Carboplatin in Adults With Advanced Solid Tumors (MK-1775-001)CompletedNCT00648648Phase 1Results posted
• Hepatic Arterial Infusion of Floxuridine, Gemcitabine Hydrochloride, and Radiolabeled Monoclonal Antibody Therapy in Treating Liver Metastases in Patients With Metastatic Colorectal Cancer Previously Treated With SurgeryCompletedNCT00645710Phase 1/2Results posted
• Phase II Clinical Trial of Gemcitabine and Doxil® for Metastatic Renal Cell CarcinomaCompletedNCT00630409Phase 2Results posted
• Monoclonal Antibody RAV12 and Gemcitabine in Treating Patients With Metastatic Pancreatic CancerTerminatedNCT00625586Phase 2Results posted
• Gemcitabine Plus Bevacizumab in Locally Recurrent or Metastatic Breast CancerCompletedNCT00623233Phase 2Results posted
• A Study of Biweekly Gemcitabine, Paclitaxel, and Avastin in Patients With Metastatic Breast CancerCompletedNCT00618826Phase 2Results posted
• Study to Evaluate Treatment Customized According to RAP80 and BRCA1 in Patients With Advanced Lung CarcinomaTerminatedNCT00617656Phase 3Results posted
• Adenocarcinoma of the Pancreas Treated With Panitumumab and Gemcitabine Regimen to Investigate Overall Survival as Primary EndpointTerminatedNCT00613730Phase 2Results posted
• Perioperative Therapy for Resectable Pancreatic CancerCompletedNCT00609336Phase 2Results posted
• A Study of Gemcitabine and Cisplatin/Carboplatin Plus Erlotinib in Patients With Nasopharyngeal CancerCompletedNCT00603915Phase 2Results posted
• Dose-Escalation Study of Intensity-Modulated Radiotherapy(IMRT)in Patients With Unresectable Pancreatic CancerCompletedNCT00593866Phase 1/2Results posted
• A Phase II Study of Pemetrexed Plus Gemcitabine for Metastatic/Recurrent Head and Neck Cancer (HNSCC)CompletedNCT00589667Phase 2Results posted
• Phase II Trial of Gemcitabine, Carboplatin, and Bevacizumab in Chemotherapy Naive Patients With Advanced/Metastatic Urothelial CarcinomaCompletedNCT00588666Phase 2Results posted
• Neoadjuvant ABI-007, Carboplatin and Gemcitabine in Locally Advanced Bladder CancerCompletedNCT00585689Phase 2Results posted
• Bevacizumab Plus Gemcitabine, Docetaxel, Melphalan, and Carboplatin in Ovarian Cancer PatientsTerminatedNCT00583622Phase 2Results posted
• Gemcitabine Hydrochloride and Tanespimycin in Treating Patients With Stage IV Pancreatic CancerCompletedNCT00577889Phase 2Results posted
• Combination Chemotherapy Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or High-Risk Primary Refractory Hodgkin LymphomaCompletedNCT00574496Phase 2Results posted
• Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube CancerActive, not recruitingNCT00565851Phase 3Results posted
• FDG-Labeled PET Scan in Planning Chemotherapy in Treating Patients With Stage IIIB or IV Non-Small Cell Lung CancerCompletedNCT00564733Phase 2Results posted
• Study Of CP-751,871 In Combination With Cisplatin And Gemcitabine In Chemotherapy-Naïve Patients With Advanced Non-Small Cell Lung CancerCompletedNCT00560573Phase 1Results posted
• Efficacy of Neoadjuvant Chemoradiation for Potentially Resectable Pancreas CancerCompletedNCT00557492Phase 2Results posted
• Combination Sunitinib and Gemcitabine in Sarcomatoid and/or Poor-risk Patients With Metastatic Renal Cell CarcinomaCompletedNCT00556049Phase 2Results posted
• Chemotherapy Followed by Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Locally Advanced Head And Neck CancerCompletedNCT00544414Phase 2Results posted
• CC-4047 With Gemcitabine for Untreated Advanced Carcinoma of the PancreasCompletedNCT00540579Phase 1/2Results posted
• Gemcitabine and Oxaliplatin in Treating Patients With Pancreatic Cancer That Can Be Removed By SurgeryCompletedNCT00536874Phase 2Results posted
• Surgery, Gemcitabine, Cisplatin, and Radiation Therapy in Treating Patients With Stage II or Stage III Non-Small Cell Lung CancerTerminatedNCT00530634Phase 2Results posted
• Open-label Study of CS-1008 for Subjects With Untreated and Unresectable Pancreatic CancerCompletedNCT00521404Phase 2Results posted
• Phase II Study Alimta and Gemzar + Avastin as First Line Chemotherapy for Elderly Patients With Stage IIIB/IV NSCLCCompletedNCT00517595Phase 2Results posted
• Gemcitabine and Doxorubicin in Treating Patients With Recurrent or Progressive Head and Neck CancerCompletedNCT00509665Phase 2Results posted
• Study Using a Genomic Predictor of Platinum Resistance to Guide Therapy in Stage IIIB/IV Non-Small Cell Lung CancerTerminatedNCT00509366Phase 2Results posted
• Abraxane, Avastin, and Gemcitabine as First-Line Therapy for Patients With Metastatic Breast CancerCompletedNCT00503906Phase 2Results posted
• Capecitabine, Gemcitabine, and Bevacizumab in Combination for Patients With Sarcomatoid Renal Cell CarcinomaCompletedNCT00496587Phase 2Results posted
• Pemetrexed Plus Gemcitabine in Renal Cell CancerTerminatedNCT00491075Phase 2Results posted
• Study of Pralatrexate & Gemcitabine With B12 & Folic Acid to Treat Relapsed/Refractory Lymphoproliferative MalignanciesCompletedNCT00481871Phase 1/2Results posted
• Gemcitabine, Paclitaxel, Doxorubicin in Metastatic or Unresectable Bladder Cancer With Decreased Kidney FunctionCompletedNCT00478361Phase 2Results posted
• A Phase II Safety and Tolerability Study of Bevacizumab When Added to Single-agent Chemotherapy to Treat Patient With Breast Cancer Metastatic to BrainTerminatedNCT00476827Phase 2Results posted
• Oxaliplatin and Gemcitabine Followed by Radiation Therapy in the Management of Mixed Mullerian Tumors of the UterusCompletedNCT00476086Phase 2Results posted
• Trial of Chemotherapy and Avastin as Treatment for Women With Breast Cancer at High Risk for RelapseTerminatedNCT00462865Phase 2Results posted
• Trial of Gemcitabine, Carboplatin, and Sorafenib in Chemotherapy-naive Patients With Advanced/Metastatic Bladder CarcinomaCompletedNCT00461851Phase 2Results posted
• A Study of Tarceva (Erlotinib) in Combination With Gemcitabine in Unresectable and/or Metastatic Cancer of the Pancreas: Relationship Between Skin Toxicity and SurvivalCompletedNCT00461708Phase 2Results posted
• Study of Gemcitabine and Oxaliplatin With Radiation Therapy in Patients With Pancreatic CancerCompletedNCT00456599Phase 2Results posted
• First-Line Treatment of A Comparison of 2 Treatments in Elderly Patients With Advanced NSCLCCompletedNCT00456261Phase 2Results posted
• Investigational Agent AG-013736 In Combinations With Standard Of Care Treatments For Patient's With Advanced Solid TumorCompletedNCT00454649Phase 1Results posted
• BrUOG-PA-209: Lapatinib and Gemcitabine for Metastatic Pancreaticobiliary CancerTerminatedNCT00447122Phase 1Results posted
• S0337, Gemcitabine After Surgery in Treating Patients With Newly Diagnosed or Recurrent Bladder CancerCompletedNCT00445601Phase 3Results posted
• Pemetrexed Disodium, Gemcitabine, and Bevacizumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerTerminatedNCT00438204Phase 2Results posted
• PF-00477736 Is Being Studied In Advanced Solid Tumors In Combination With Chemotherapy With GemcitabineTerminatedNCT00437203Phase 1Results posted
• Chemotherapy for Participants With LymphomaCompletedNCT00436280Phase 2Results posted
• Gemcitabine and S-1 for Locally Advanced Unresectable or Metastatic Pancreatic CancerTerminatedNCT00429858Phase 2Results posted
• A Trial of Chemo & Radiation Therapy for Pancreatic CancerCompletedNCT00424827Phase 2Results posted
• Clinical Trial of MK0683 in Combination With FDA Approved Cancer Drugs in Patients With Advanced NSCLC (MK0683-058)CompletedNCT00423449Phase 1Results posted
• Oxaliplatin, Gemcitabine and Bevacizumab in Women With Recurrent Mullerian CarcinomaTerminatedNCT00418093Phase 2Results posted
• Gemcitabine, Infusional 5 Fluorouracil and Bevacizumab in Patients With Advanced Pancreas CancerCompletedNCT00417976Phase 2Results posted
• Cetuximab, Gemcitabine, and Oxaliplatin Followed By Surgery or External-Beam Radiation Therapy and Capecitabine in Treating Patients With Locally Advanced, Nonmetastatic Pancreatic Cancer That Cannot Be Removed By SurgeryCompletedNCT00408564Phase 2Results posted
• Chemotherapy With or Without Bevacizumab in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer That Can Be Removed By SurgeryStatus unknownNCT00408408Phase 3Results posted
• Pemetrexed Disodium and Gemcitabine in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerCompletedNCT00407550Phase 2Results posted
• Phase 2 Study of Gemzar, Taxol & Avastin Combination as 1st Line Treatment for Metastatic Breast CancerCompletedNCT00403130Phase 2Results posted
• Carboplatin and Gemcitabine With Bevacizumab Every 2 Weeks for Stage IIIb/IV Non-small Cell Lung CancerCompletedNCT00400803Phase 2Results posted
• Gemcitabine Plus Albumin-bound Paclitaxel In Patients With Advanced Metastatic Pancreatic CancerCompletedNCT00398086Phase 1/2Results posted
• Pemetrexed and Gemcitabine in Patients With Advanced Head and Neck CancerTerminatedNCT00394147Phase 2Results posted
• Low Dose Upper Abdominal Radiation Therapy (LD-UART) + Gemcitabine in Patients With Advanced, Unresectable Pancreatic Cancer (PC)CompletedNCT00390182Phase 1/2Results posted
• Gemcitabine and Hodgkin's Disease Chemotherapy Followed by Peripheral Blood Stem Cell Rescue for Hodgkin's DiseaseCompletedNCT00388349Phase 2Results posted
• Gemcitabine and Cisplatin for Advanced or Recurrent Endometrial CancerCompletedNCT00388154Phase 2Results posted
• Allogeneic Blood Stem Cell Transplantation and Adoptive Immunotherapy for Hodgkin's DiseaseCompletedNCT00385788Phase 2Results posted
• Pemetrexed and Gemcitabine Every 14 Days Versus Every 21 Days in Advanced Non Small Cell Lung CancerTerminatedNCT00383331Phase 2Results posted
• A Study of Romidepsin (Depsipeptide) in Combination With Gemcitabine in Patients With Pancreatic and Other Advanced Solid TumorsCompletedNCT00379639Phase 1Results posted
• Multicenter Evaluation of Docetaxel, Gemcitabine, and Bevacizumab Combination Followed by Bevacizumab Alone in Subjects With Locally Advanced or Metastatic Non-Small Cell Lung CancerTerminatedNCT00378573Phase 2Results posted
• Genistein, Gemcitabine, and Erlotinib in Treating Patients With Locally Advanced or Metastatic Pancreatic CancerCompletedNCT00376948Phase 2Results posted
• Gemcitabine and Pemetrexed Disodium in Treating Patients With Advanced Mycosis Fungoides or Sézary SyndromeTerminatedNCT00369629Phase 1Results posted
• Gemcitabine, Bevacizumab and Erlotinib in Pancreatic CancerCompletedNCT00366457Phase 2Results posted
• Gemcitabine, Oxaliplatin in Combination With Bevacizumab in Biliary Tract and Gallbladder CancerCompletedNCT00361231Phase 2Results posted
• Chemotherapy Treatment in Re-occurring Non Small Cell Lung Cancer (NSCLC) After Previous Chemotherapy and Surgical Removal of the NSCLC TumorTerminatedNCT00356525Phase 2Results posted
• Trilogy Stereotactic Body Radiotherapy for Pancreatic CancerCompletedNCT00350142Phase 2Results posted
• Induction Cetuximab (IM-C225), Gemcitabine, and Oxaliplatin in Pancreatic Cancer PatientsCompletedNCT00338039Phase 2Results posted
• A Phase II Study of Gemcitabine and Erlotinib As Adjuvant Therapy In Patients With Resected Pancreatic CancerTerminatedNCT00336700Phase 2Results posted
• Combination Chemotherapy of Gemcitabine and Paclitaxel for Metastatic Breast CancerCompletedNCT00334802Phase 2Results posted
• Cetuximab and Bevacizumab With or Without Gemcitabine to Treat Metastatic Pancreatic CancerTerminatedNCT00326911Phase 2Results posted
• Phase II Bevacizumab, Gemcitabine and Carboplatin in Newly Diagnosed Non-Small Cell Lung CancerCompletedNCT00323869Phase 2Results posted

← Gemcitabine overview